ENZN 0.16 Enzon Pharmaceuticals, Inc.
| Range: | 0.06-0.24 | Vol Avg: | 17351 | Last Div: | 0 | Changes: | 0.01 |
| Beta: | 0.48 | Cap: | 0.01B | Currency: | USD | Exchange: | PNK |
| Sector: | Healthcare | IPO: | Wed Feb 15 1984 | Empoloyees: | |||
| CUSIP: | 293904108 | CIK: | 0000727510 | ISIN: | US2939041081 | Country: | US |
| CEO: | Mr. Richard L. Feinstein CPA | Website: | https://www.enzon.com | ||||
Enzon Pharmaceuticals, Inc., together with its subsidiaries, engages in marketing drug products. The company's marketed drug product is PegIntron. It also has a marketing agreement relating to Vicineum drug. The company was founded in 1981 and is headquartered in Cranford, New Jersey.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow